Is Using Wegovy for One Month Worth It?

The biggest misconception: one month is a fair trial

The most common reason people conclude Wegovy "didn't work" after a month is a misunderstanding of what the first four weeks are for. At the start of treatment, the dose isn't set to produce weight loss, it is set to let your digestive system get used to a new medicine. Nausea, a reduced appetite for certain foods, and a feeling of fullness after small meals can all appear quickly. But the scale may barely move, and that is expected.

STEP 1, the pivotal semaglutide trial published in the New England Journal of Medicine, followed 1,961 adults over 68 weeks. Average weight reduction of around 15% was recorded, but that was the cumulative result of a carefully staged dose escalation. Nobody reached that figure at week four. Participants were still on the starter dose.

Stopping at one month because results feel modest is a bit like judging a course of antibiotics at day two. The medicine hasn't been given the conditions it needs. This isn't a defence of any particular outcome, some people do stop early for clinical reasons, and that is always a matter for a prescriber. It is simply a correction to the framing that one month constitutes a meaningful test.

What does tend to happen in the first four weeks

Early changes are real, even if they don't show up dramatically on the scales. Many people describe a shift in how hunger feels, less urgent, easier to ignore. Portion sizes that previously felt automatic start to feel like a conscious choice. Some people find that foods they craved regularly become less appealing. These appetite changes are the medicine beginning to do its job, even at a low dose.

Side effects are also most concentrated here. Nausea, loose stools, constipation or indigestion are the most frequently reported early reactions, according to the NHS semaglutide medicines page. They are typically mild to moderate and settle for most people over the following weeks, particularly after each dose increase passes. Keeping the pen in the fridge door and injecting on the same day each week helps build a consistent routine that many people find makes the early weeks more manageable.

For those wondering when Wegovy's effects become noticeable, the honest answer is that appetite changes often come first, with scale changes following over subsequent months. Understanding that sequence prevents a lot of premature disappointment.

So is one month worth the cost?

This is the practical question underneath the clinical one, and it deserves a straight answer. One month on its own is not where the value of Wegovy sits. The medicine is designed as a medium-to-long-term treatment, and the NICE appraisal of semaglutide (TA875) reflects that: the recommendation for NHS use caps treatment at two years within a specialist service, recognising that sustained benefit requires sustained treatment. Private treatment has no arbitrary time limit, but the logic holds, the case for Wegovy is built on what it does over months, not weeks.

That said, one month is worth it in a different sense: it is the necessary entry point. There is no route to month six without month one. Completing the starter phase, letting side effects settle, and arriving at a dose where the medicine's appetite-regulating effects are properly active is the whole point of the early weeks. Viewing month one as an investment rather than a result changes the calculation considerably.

For a clearer sense of what the cost of treatment involves over time, this price comparison page sets out the UK private market context honestly. And if you want to read about the broader question of whether the treatment is justified, this page looks at the evidence for long-term weight loss with Wegovy in more detail.

Making an informed decision before you start

Committing to Wegovy is a clinical decision, not a purchase. A prescriber needs to assess your health history, current medicines, BMI and any relevant conditions before a prescription can be issued, that is a legal requirement for any prescription-only medicine, and it also happens to be protective. Starting with realistic expectations is part of that conversation.

People who do best on Wegovy tend to treat the first month as orientation: establishing the injection routine, noting how appetite shifts, managing any early side effects, and preparing for the dose increase. Those who judge it purely on scale movement in week four often exit before the medicine has had a fair chance.

If you are weighing up whether treatment is right for your situation, this guide to starting Wegovy covers what the process looks like in practice. You can also read about what one month of Wegovy typically involves in more granular terms, what to track, what is normal, and what to flag to a prescriber. Our clinical team, led by a GPhC-registered Independent Prescriber, reviews every consultation individually. If you are ready to take that step, speak to our prescribers through a free consultation.